| abstract |
(57) [Summary] The present invention relates to two single-chain bloods having at least one C α atom independently substituted by an alkyl group, with a bridging group having the C α atom of a non-terminal amino acid bonded to the end thereof. The present invention relates to a peptide compound consisting of a peptide having a regulatory action, for example, a hematopoiesis inhibiting action. The disclosed cross-linked dipeptide compounds have stimulatory activity on cell division, especially myelopoietic and myeloid cells. |